Product Information
DESMOPRESSIN 0.01% SOLUTION is a generic product labeled by Bauch & Lomb Incorporated, priced at $23.9168 per ML under NDC 24208034205. Its NADAC has been published 431 times since Nov 28, 2013.
FDA first approved this application on Jan 25, 1999.
Strength
.1 mg/mL
Manufacturer
Bauch & Lomb IncorporatedNDC
24208034205
Classification
Generic
Dosage Form
SOLUTION
Route
NASAL
Effective Date
2/18/2026
Active Ingredients
DESMOPRESSIN ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA074830FDA Approved
1/25/1999
On Market Since
1/25/1999
Pharmacological Classes
Price Statistics
The NADAC for DESMOPRESSIN 0.01% SOLUTION has been published 431 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.9168 per ML |
|---|---|
| All-time high | $34.6274 (Apr 10, 2019) |
| All-time low | $13.4228 (Oct 18, 2017) |
| 52-week high | $24.1678 |
| 52-week low | $21.0712 |
| Median price | $20.8727 |
| Average price | $23.2843 |
| Largest weekly change | +59.0% (Jul 11, 2018) |
| Weeks tracked | 431 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+13.5%
3Y
-30.9%
5Y
-30.9%
All
+0.6%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Desmopressin Acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bauch & Lomb Incorporated manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Desmopressin Acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor VIII Activator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DESMOPRESSIN 0.01% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for DESMOPRESSIN 0.01% SOLUTION, manufactured by Bauch & Lomb Incorporated, is $23.9168 per ML (NDC 24208034205), effective Feb 18, 2026.
How has the price of DESMOPRESSIN 0.01% SOLUTION changed over time?
Over the history we have for it, the NADAC for DESMOPRESSIN 0.01% SOLUTION has held within roughly two percent of its current level. It has been tracked across 431 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for DESMOPRESSIN 0.01% SOLUTION?
Since Nov 28, 2013, the NADAC for DESMOPRESSIN 0.01% SOLUTION has ranged from a low of $13.4228 (Oct 18, 2017) to a high of $34.6274 (Apr 10, 2019), with a median of $20.8727 per ML.
Are there cheaper alternatives to DESMOPRESSIN 0.01% SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of DESMOPRESSIN 0.01% SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DESMOPRESSIN 0.01% SOLUTION?
DESMOPRESSIN 0.01% SOLUTION (NDC 24208034205) is labeled by Bauch & Lomb Incorporated, and CMS classifies it as a generic product.